• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曼氏血吸虫病和班氏丝虫病患者治疗后的嗜酸性粒细胞增多症。

Eosinophilia following treatment of patients with schistosomiasis mansoni and Bancroft's filariasis.

作者信息

Ottesen E A, Weller P F

出版信息

J Infect Dis. 1979 Mar;139(3):343-7. doi: 10.1093/infdis/139.3.343.

DOI:10.1093/infdis/139.3.343
PMID:448186
Abstract

Eosinophilia is frequently observed after treatment of patients with infections due to parasitic helminths. For definition of the characteristics and causes of post-treatment eosinophilic responses, 47 patients with Bancroft's filariasis, who were treated with diethylcarbamazine, and eight patients with schistosomiasis mansoni, who were treated with niridazole, were studied. After therapy for eight days, both groups developed significant (P less than 0.05) increases in their levels of eosinophilia, which peaked in two to four weeks. Maximal levels averaged two and one-half to three time the levels before treatment. Before therapy the number of circulating eosinophils was unrelated to intensity of infection in both groups, but after treatment, when the same relationship was examined in the larger group (the patients with filariasis), the degree of post-treatment eosinophilia was significantly correlated with the patients' worm burdens before treatment (r = 0.727; P less than 0.001). Thus, treatment of helminthic infections can provide a unique opportunity for studying eosinophil responses of humans to graded doses of antigen and has shown that acute responses are determined quantitatively by the amount of antigen initially presented to the host.

摘要

在使用抗寄生虫蠕虫药物治疗感染患者后,经常会观察到嗜酸性粒细胞增多的现象。为了明确治疗后嗜酸性粒细胞反应的特征和原因,对47例接受乙胺嗪治疗的班氏丝虫病患者和8例接受硝唑咪治疗的曼氏血吸虫病患者进行了研究。治疗八天后,两组患者的嗜酸性粒细胞水平均显著升高(P<0.05),并在两到四周内达到峰值。最高水平平均为治疗前的二点五到三倍。治疗前,两组患者循环嗜酸性粒细胞的数量与感染强度无关,但在治疗后,对较大的一组(丝虫病患者)进行同样关系的检查时,治疗后嗜酸性粒细胞增多的程度与患者治疗前的虫负荷显著相关(r=0.727;P<0.001)。因此,蠕虫感染的治疗为研究人类对分级剂量抗原的嗜酸性粒细胞反应提供了一个独特的机会,并表明急性反应在数量上由最初呈现给宿主的抗原量决定。

相似文献

1
Eosinophilia following treatment of patients with schistosomiasis mansoni and Bancroft's filariasis.曼氏血吸虫病和班氏丝虫病患者治疗后的嗜酸性粒细胞增多症。
J Infect Dis. 1979 Mar;139(3):343-7. doi: 10.1093/infdis/139.3.343.
2
Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.班氏丝虫病患者治疗后出现嗜酸性粒细胞增多以及血清嗜酸性粒细胞主要碱性蛋白和夏科-莱登结晶蛋白(溶血磷脂酶)水平升高。
J Immunol. 1981 Sep;127(3):1093-8.
3
Low-dose niridazole in the treatment of Schistosoma mansoni.
Ann Trop Med Parasitol. 1979 Jun;73(3):295-6. doi: 10.1080/00034983.1979.11687261.
4
[Imported parasitic diseases: apropos of 4 cases of schistosomiasis].[输入性寄生虫病:关于4例血吸虫病]
Union Med Can. 1971 May;100(5):930-5.
5
Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophilia.旅行相关的血吸虫病、类圆线虫病、丝虫病和弓蛔虫病:感染风险和血液嗜酸性粒细胞增多的诊断相关性。
BMC Infect Dis. 2011 Apr 5;11:84. doi: 10.1186/1471-2334-11-84.
6
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.嗜酸性粒细胞增多症患者的嗜酸性粒细胞增强的杀蠕虫能力。
N Engl J Med. 1980 Nov 13;303(20):1147-52. doi: 10.1056/NEJM198011133032004.
7
Sustained release of niridazole from silicone rubber implants for the treatment of Schistosoma mansoni infections.用于治疗曼氏血吸虫感染的含硝唑从硅橡胶植入物中的缓释。
Am J Trop Med Hyg. 1980 Jan;29(1):71-3. doi: 10.4269/ajtmh.1980.29.71.
8
Serum antibody and eosinophil changes after treatment of human Manson's schistosomiasis with niridazole or hycanthone.硝唑咪或羟氨喹治疗人类曼氏血吸虫病后血清抗体和嗜酸性粒细胞的变化
Rev Inst Med Trop Sao Paulo. 1971 Mar-Apr;13(2):121-30.
9
The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man.人类急性和慢性血吸虫病中抗原特异性细胞免疫反应性的获得与丧失
Clin Exp Immunol. 1978 Jul;33(1):37-47.
10
Schistosomiasis: clinical features and relevance to hematology.血吸虫病:临床特征及其与血液学的关联
Semin Hematol. 1982 Apr;19(2):132-40.

引用本文的文献

1
Therapy and Prevention for Human Toxocariasis.人类弓首蛔虫病的治疗与预防
Microorganisms. 2022 Jan 22;10(2):241. doi: 10.3390/microorganisms10020241.
2
Review of Dancing Parasites in Lymphatic Filariasis.淋巴丝虫病中舞动寄生虫的综述。
Ultrasound Int Open. 2019 Mar;5(2):E65-E74. doi: 10.1055/a-0918-3678. Epub 2019 Jul 15.
3
How I treat hypereosinophilic syndromes.我如何治疗高嗜酸性粒细胞综合征。
Blood. 2015 Aug 27;126(9):1069-77. doi: 10.1182/blood-2014-11-551614. Epub 2015 May 11.
4
Eosinophilic pneumonias.嗜酸性粒细胞性肺炎。
Clin Microbiol Rev. 2012 Oct;25(4):649-60. doi: 10.1128/CMR.00025-12.
5
Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.曼氏血吸虫感染中嗜酸性粒细胞在体内和体外的活性与吡喹酮治疗前后血浆细胞因子谱的关系。
Clin Vaccine Immunol. 2006 May;13(5):584-93. doi: 10.1128/CVI.13.5.584-593.2006.
6
Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis.淋巴丝虫病治疗后嗜酸性粒细胞稳态的扰动。
Infect Immun. 2000 Jan;68(1):93-9. doi: 10.1128/IAI.68.1.93-99.2000.
7
The human eosinophil: roles in host defense and tissue injury.人类嗜酸性粒细胞:在宿主防御和组织损伤中的作用。
Am J Pathol. 1980 Sep;100(3):791-820.
8
Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis.白细胞介素-5与盘尾丝虫病患者治疗后的嗜酸性粒细胞增多症
J Clin Invest. 1991 Oct;88(4):1418-21. doi: 10.1172/JCI115449.